DeepMed Research

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Feasibility of a Touch Screen Computer Based Breast-feeding Educational Support Program

Not Applicable

Completed

Conditions: Pregnancy Related

Interventions: Behavioral: Breastfeeding computer education

First Posted Date: 2017-10-12

Last Posted Date: 2023-09-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 46

Registration Number: NCT03308058

Locations: 🇺🇸
University of Nebraska Medical Center, Regional West Medical Center, Scottsbluff, Nebraska, United States

Mother and Child Health Outcomes After Maternal Bariatric Surgery

Not Applicable

Completed

Conditions: Weight Loss

Interventions: Behavioral: Presurgical Counseling

First Posted Date: 2017-09-29

Last Posted Date: 2023-09-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 5

Registration Number: NCT03297307

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

Phase 1

Completed

Conditions: HIV Prevention

Interventions: Drug: Tenofovir Disoproxil Fumarate/Emtricitabine

First Posted Date: 2017-09-01

Last Posted Date: 2023-09-15

Lead Sponsor: University of Nebraska

Target Recruit Count: 15

Registration Number: NCT03270969

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Impact of Oral Hygiene Gels on Peri-implant Mucositis

Not Applicable

Completed

Conditions: Mucositis

Interventions: Other: Aquafresh gel
Other: Livionex gel

First Posted Date: 2017-08-09

Last Posted Date: 2023-09-26

Lead Sponsor: University of Nebraska

Target Recruit Count: 21

Registration Number: NCT03243591

Locations: 🇺🇸
University of Nebraska Medical Center, College of Dentistry, Lincoln, Nebraska, United States

Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia

Phase 2

Completed

Conditions: Adult Acute Myeloid Leukemia
Secondary Acute Myeloid Leukemia
Therapy-Related Acute Myeloid Leukemia

Interventions: Drug: Cytarabine
Drug: Decitabine
Drug: Idarubicin
Other: Laboratory Biomarker Analysis
Drug: Liposome-encapsulated Daunorubicin-Cytarabine
Other: Quality-of-Life Assessment
Drug: Azacitidine
Other: Questionnaire Administration
Drug: Venetoclax
Drug: glasdegib

First Posted Date: 2017-07-21

Last Posted Date: 2024-12-16

Lead Sponsor: University of Nebraska

Target Recruit Count: 75

Registration Number: NCT03226418

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Loop Duodenal Switch: Outcomes at One Year

Not Applicable

Terminated

Conditions: Obesity, Morbid

Interventions: Other: Loop DS surgery

First Posted Date: 2017-07-02

Last Posted Date: 2023-08-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 1

Registration Number: NCT03206736

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma

Phase 1

Terminated

Conditions: Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Refractory Multiple Myeloma

Interventions: Drug: Cabozantinib

First Posted Date: 2017-06-28

Last Posted Date: 2023-09-08

Lead Sponsor: University of Nebraska

Target Recruit Count: 11

Registration Number: NCT03201250

Locations: 🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Hand-sewn and Linear-stapled Roux-en-Y Gastric Bypass: Outcomes

Withdrawn

Conditions: Roux-en-y Anastomosis Site

Interventions: Other: RYGB hand-sewn
Other: RYGB linear-staple

First Posted Date: 2017-06-26

Last Posted Date: 2023-08-22

Lead Sponsor: University of Nebraska

Registration Number: NCT03199352

Early Rheumatoid Arthritis Lung Disease Study

Recruiting

Conditions: Rheumatoid Arthritis

First Posted Date: 2017-06-20

Last Posted Date: 2025-05-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 100

Registration Number: NCT03192267

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer

Phase 2

Recruiting

Conditions: Stage III Pancreatic Cancer AJCC v6 and v7
Pancreatic Adenocarcinoma
Stage IB Pancreatic Cancer AJCC v6 and v7
Stage IIA Pancreatic Cancer AJCC v6 and v7
Recurrent Pancreatic Carcinoma
Stage I Pancreatic Cancer AJCC v6 and v7
Stage IA Pancreatic Cancer AJCC v6 and v7
Stage IV Pancreatic Cancer AJCC v6 and v7
Stage II Pancreatic Cancer AJCC v6 and v7
Stage IIB Pancreatic Cancer AJCC v6 and v7

Interventions: Drug: Capecitabine
Drug: Fluorouracil
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study
Radiation: Stereotactic Body Radiation Therapy
Drug: Zoledronic Acid

First Posted Date: 2017-03-08

Last Posted Date: 2025-04-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 44

Registration Number: NCT03073785

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy